Practice guide of drug monitoring and management for the treatment of inflammatory bowel disease in children in China(2023)

Title: Practice guide of drug monitoring and management for the treatment of inflammatory bowel disease in children in China(2023)
Edition: Original
Classification: Experts consensus
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: pediatrician
Evidence classification method: 德尔菲法
Development unit: Shengjing Hospital of China Medical University
Registration time: 2023-09-20
Registration number: PREPARE-2023CN403
Purpose of the guideline: To provide unified standards and standardized recommendations for the monitoring of therapeutic drugs for children with inflammatory bowel disease in China